Intravenous drug abuse and Type 1 diabetes: Financial and healthcare implications

Diabetic Medicine

Volumn 21, Issue 12, 2004, Pages 1269-1273

  Saunders, S A ^a   Democratis, J ^a   Martin, J ^a   Macfarlane, I A ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Diabetic ketoacidosis; Heathcare costs; Hospital inpatients; Intravenous drug abuse; Type 1 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC KETOACIDOSIS; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ABUSE; MALE; MORBIDITY; MORTALITY; TEACHING HOSPITAL; UNITED KINGDOM;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; MALE; MORBIDITY; RECURRENCE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 10244251643     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01325.x     Document Type: Article

References (16)

1. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000; 355: 873-876.
2. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
3. Scott LJ, Warram JH, Hanna LS, Laffel LM, Ryan L, Krolewski AS. A nonlinear effect of hyperglycaemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 2001; 50: 2842-2849.
4. French MT, McGreary KA, Chitwood DD, McCoy CB. Chronic illicit drug use, health services utilisation and the cost of medical care. Social Sci Med 2000; 50: 1703-1713.
5. Stein MD, Sobata M. Injection drug users, hospital care and charges. Drug Alcohol Dependence 2001; 64: 117-120.
6. Basu A, Close CF, Jenkins D, Krentz AJ, Nattrass M, Wright AD. Persisting mortality in diabetic ketoacidosis. Diabet Med 1993; 10: 282-284.
7. Hamblin PS, Topliss DJ, Chosich N, Lording DW, Stockigt JR. Deaths associated with diabetic ketoacidosis and hyperosmolar coma 1973-88. Med J Aust 1989; 152: 327-328.
8. McColl MD, Tait RC, Greer IA, Walker ID. Injecting drug use is a risk factor for deep vein thrombosis in women in Glasgow. Br J Haematol 2001; 112: 641-643.
9. Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case control study. Clin Infect Dis 2001; 33: 35-40.
10. Griffin SJ. Lost to follow-up: the problem of defaulters from diabetes clinics. Diabet Med 1998; 15: S14-24.
11. Dyer PH, Lloyd CE, Lancashire RJ, Bain SC, Barnett AH. Factors associated with clinic non-attendance in adults with type 1 diabetes mellitus. Diabet Med 1998; 15: 339-343.
12. MacFarlane IA, Gill GV, Massen E, Tucker NH. Diabetes in prison: can good diabetic care be achieved? BMJ 1992; 304: 152-155.
13. Braatvedt G, Rowan J, Atherfold C. A cross-sectional study of diabetes in Mt Eden Prison. Auckland NZ Med J 1994; 107: 292-293.
14. Frischer M, Goldberg D, Rahman M, Berney L. Mortality and survival among a cohort of drug injectors in Glasgow. Addiction 1997; 92: 419-427.
15. Canning U, Kennell-Webb SA, Marshall EJ, Wessely SC, Peters TJ. Substance misuse in acute general medical admissions. QJM 1999; 92: 319-326.
16. Squires NF, Beeching NJ, Schlecht BJ, Ruben SM. An estimate of the prevalence of drug misuse in Liverpool and a spatial analysis of known addiction. J Public Health Med 1995; 17: 103-109.